Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,440.00    -50.00 (-3.36%)
Bid:
1,434.00
Ask:
1,442.00
Spread: 8.00 (0.558%)
Market Cap: £493.01m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Statement

11 Jan 2008 07:01

Craneware plc11 January 2008 Craneware plc ("Craneware" or the "Company") H1 TRADING UPDATE 11 January 2008 - Craneware plc, (AIM: CRW) a leader in revenue cyclemanagement software solutions for the US healthcare market, is pleased to givean update today on trading during the half year to 31 December 2007. Following the Company's IPO on AIM in September 2007, Craneware has executed onits strategy to further advance its market leading position. In the six monthsto 31 December 2007, the Company signed up 96 new hospitals, compared to 64 inthe previous corresponding period. As a result, the Company's software is nowbeing used in 878 hospitals in the US, up from 800 at the beginning of the year. Revenue for the first half of the year was in line with management expectations,with new sales bookings being over 50% higher than the previous correspondingperiod. Craneware's flagship product, Chargemaster Toolkit(R), was also onceagain named top in its class by the prestigious industry research house KLAS inthe US. As stated at the time of the IPO, the Company believes there is a significantopportunity to sell additional software products into its customer base and assuch has added two further products to its suite aimed at the finance departmentof US hospitals. In November, Craneware launched Patient Charge Estimator(TM),which enables hospitals to efficiently and accurately provide prospectivepatients with estimates of procedural charges. Yesterday the Company launchedPharmacy ChargeLink(TM) which enables hospitals to improve the buying, billing and reimbursement of pharmacy items. Craneware has started the second half of the year with a strong pipeline ofsales prospects and this together with the new product launches gives managementconfidence for the Company's performance for the full year. Overall, significantprogress has been made in H1 and the Company anticipates further positivenewsflow in H2. Craneware will be announcing Interim results on Tuesday 26thFebruary 2008. Keith Neilson, CEO of Craneware, commented, "We are delighted with the progressmade during the first few months of life as a public company. Cranewarecontinues to grow and we have maintained our leading position as a provider ofrevenue cycle management software to US hospitals. The complexity of legislationgoverning this sector, and the high proportion of hospitals still using manualsolutions to manage their revenue cycles, means we are operating in a vibrantmarketplace with opportunity for growth alongside continuing high levels ofcontract renewals. We look forward to updating shareholders in February." For further information, please contact: Craneware plc KBC Peel Hunt ICIS+44 (0)1506 407 666 +44 (0)20 7418 8900 +44 (0)20 7651 8688Keith Neilson, CEO Oliver Scott Tom MoriartySandy McDougall, CFO Deon Veldtman Caroline Evans-Jones About Craneware Founded in 1999, Craneware has headquarters in Livingston, Scotland, withoffices in Florida, Arizona and Kansas, employing approximately 100 staff. TheCompany's flagship product, Chargemaster Toolkit(R) ("CMT"), assists UShealthcare providers in reducing billing errors, ensuring the timely andaccurate submission of claims and managing compliance risk. More informationabout Craneware plc and its services can be found on-line at the Company'scorporate website, www.craneware.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Dec 20201:11 pmRNSHolding(s) in Company
1st Dec 20201:22 pmRNSHolding(s) in Company
26th Nov 20207:00 amRNSAppointment of Joint Broker
20th Nov 20205:49 pmRNSDividend Currency Election
17th Nov 20201:47 pmRNSHolding(s) in Company
17th Nov 20201:30 pmRNSResult of AGM
17th Nov 20207:00 amRNSAGM Statement
19th Oct 20207:00 amRNSNotice of AGM & Q1 Trading Update
15th Oct 20207:00 amRNSBlock listing Interim Review
2nd Oct 20203:55 pmRNSGrant of Long Term Incentive Plan Awards
21st Sep 20207:00 amRNSFinal Results
18th Aug 20207:00 amRNSPurchase of Shares and Exercise of Share Options
12th Aug 20207:00 amRNSUpdate on Proposed Placing
11th Aug 20205:00 pmRNSProposed Accelerated Bookbuild
8th Jul 20207:00 amRNSTrading Update
18th Jun 20202:37 pmRNSHolding(s) in Company
21st Apr 20205:04 pmRNSGrant of Share Options
20th Apr 202011:05 amRNSSecond Price Monitoring Extn
20th Apr 202011:00 amRNSPrice Monitoring Extension
15th Apr 20205:15 pmRNSBlock listing Interim Review
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
26th Mar 20204:31 pmRNSVesting of Long Term Incentive Plan Award
20th Mar 20202:02 pmRNSDividend Currency Election
20th Mar 20209:00 amRNSBlocklisting Application
3rd Mar 20207:00 amRNSHalf-year Report
24th Feb 20207:00 amRNSBoard Appointments
23rd Jan 20202:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20202:00 pmRNSPrice Monitoring Extension
23rd Jan 20207:00 amRNSTrading Update and Notice of Results
23rd Dec 20193:15 pmRNSDirector/PDMR Shareholding and Total Voting Rights
20th Dec 201912:10 pmRNSHolding(s) in Company
29th Nov 201912:29 pmRNSDividend Currency Election
25th Nov 20195:23 pmRNSHolding(s) in Company
22nd Nov 201911:01 amRNSTotal Voting Rights
18th Nov 20197:00 amRNSShare Purchase by Chairman Designate
13th Nov 20194:10 pmRNSResult of AGM
12th Nov 20197:00 amRNSAGM Statement
16th Oct 201910:46 amRNSBlock listing Interim Review
11th Oct 20194:17 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20194:41 pmRNSSecond Price Monitoring Extn
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
18th Sep 20197:00 amRNSDirector/PDMR Shareholding
16th Sep 201912:03 pmRNSHolding(s) in Company
4th Sep 20196:14 pmRNSGrant of Long Term Incentive Plan Awards
3rd Sep 20197:00 amRNSFinal Results
2nd Sep 201911:23 amRNSBlocklisting Application
1st Jul 20192:00 pmRNSPrice Monitoring Extension
28th Jun 20199:05 amRNSSecond Price Monitoring Extn
28th Jun 20199:00 amRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.